Archives for April 20, 2019

Amazon asks delivery drivers to verify their identities with selfies

by

The facial recognition measure could reduce fraud and Flex account sharing.

Amazon is asking its delivery drivers to take selfies so it can verify their identities using facial recognition. The rules apply to drivers in the Amazon Flex program, through which they make deliveries with their own cars as independent contractors, the company confirmed to The Verge.

A message in the Amazon Flex app told drivers they had to take a selfie before they could continue working (though it urges them not to take photos while driving). Amazon also informed drivers it may collect their biometric data to occasionally confirm their identity. The selfie obligation could stop Flex drivers from sharing their accounts with people Amazon hasn’t authorized to make deliveries.

Drivers need to provide a photo of themselves when they sign up for the Flex program and Amazon shows the photo to customers so they can identify the delivery person. In the Flex FAQs, Amazon says it’ll use the photos of those who signed up to the platform after November 13th last year to verify drivers’ identities and for fraud detection.

However, the selfie requirement may not be entirely robust. Uber has similar identity verification measures. Reports emerged last year of transgender drivers who were suspended from the platform over selfies that didn’t match previous photos, because they were at varying points of transitioning.

Syringe ‘watch’ puts a life-saving allergy shot on your wrist

by

It would be far easier to carry than a dedicated pen.

If you’re prone to serious allergic reactions, carrying an epinephrine shot (such as an EpiPen) could be vital. Those shots are often bulky, though, and there’s a real chance you could lose yours right before you need it. Students at Rice University have a (relatively) simple solution: put the shot on your wrist. They’ve developed a wearable, the EpiWear, that hides a foldable epinephrine syringe in a device not much larger than a watch. If you’re in an emergency, you just need to unfold it, flick a safety lever and push a button when you’re ready to inject the medicine into your thigh.

The team is keenly aware of safety concerns. The three-piece folding design makes it effectively impossible to trigger the needle by accident, and there are plans for a case that would prevent the button from touching anything until the shot is necessary.

EpiWear is still very young, to the point where it’s made of 3D-printed parts. The students plan to refine it, however, including a smaller, more refined look that would be more acceptable on a night out. They’re even considering adding watch functionality so that it does more than sit on your wrist in ordinary situations. Should it become a practical reality, you might not have to feel awkward about carrying a life-saving injection with you — and you’d never have to worry about leaving it behind.

Rivian turned down GM investment so it could build EVs for others

by

GM reportedly wanted exclusivity.

Reports emerged last week that GM would not join Amazon in investing in electric vehicle startup Rivian, and now we have a little more clarity on why talks broke down. It seems GM wanted some exclusivity, but Rivian plans to build vehicles for other companies, as well as release up to six models under its own branding by 2025.

Founder RJ Scaringe said Rivian is working on something related to the Amazon investment, but hinted to Bloomberg that it may not be a vehicle. He’s open to selling his company’s technology (it has developed long-lasting batteries) to other businesses for various products, including stationary batteries. So perhaps Amazon is interested in using Rivian’s know-how for something other than vehicles, though it has also invested in a self-driving car startup.

Scaringe noted in the interview that tens of thousands of people have laid down a $1,000 deposit for Rivian’s EVs, just over half of which are for the R1T. That pickup and the R1S SUV are scheduled to go on sale next year.

Researchers suggest 100 percent renewable energy isn’t very green

by

Drilling and Explosive Loading at Open Pit Copper Mine in Northern Chile

The increased demand for metals could have social and environmental consequences.

In order to keep global temperature rise below 1.5 degrees Celsius, we’ll need to rely on renewable energy, electric vehicles (EV) and battery storage. But creating that infrastructure will dramatically increase our need for metals like cobalt and lithium. A report released this week cautions that a spike in demand for those and other metals could drain the planet’s reserves and lead to dire social and environmental consequences.

The situation is especially urgent for the EV and battery industries, according to the researchers from the Institute for Sustainable Futures. Those industries are the main drivers of demand for cobalt, with each EV requiring between five to 10 kilograms of the metal for its lithium-ion batteries. As much as 60 percent of cobalt comes from the Democratic Republic of Congo, which has already been charged with using child labor in its mines.

The researchers looked at a total of 14 metals, including those used in solar panels and wind turbines. They estimate that converting to 100 percent renewable energy could increase demand for lithium and nickel by as much as 280 percent and 136 percent, respectively. As Grist reports, the rush to meet that demand would likely increase mining in countries with lax environmental and safety regulations.

According to the report, recycling is our best bet to reduce primary demand. Companies like Apple and Amazon are already working to develop closed-loop recycling systems, but that will only get us so far. As Payal Sampat of Earthworks, which published the study, told Grist, “We’re not going to tech fix our way out of this. It’s going to require more meaningful policy changes that fundamentally reduce the overall demand.”

Stocks to Watch: Healthcare Services Group, Inc. (NasdaqGS:HCSG), Nabors Industries Ltd. (NYSE:NBR): Are Shares Undervalued?

by

Healthcare Services Group, Inc. (NasdaqGS:HCSG) has a current MF Rank of 5576. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

When undertaking stock analysis, investors might be searching for companies that are presently undervalued. Undervalued stocks may provide a higher chance of realizing big gains. Finding undervalued stocks that are high quality can be the biggest challenge for the investor. Many investors will dig into the numbers and look for companies that have been consistently making lots of money and performing well on the earnings front. 

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 1.054029.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  

The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 1.131988.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

The Return on Invested Capital (aka ROIC) for Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 0.287029.  The Return on Invested Capital is a ratio that determines whether a company is profitable or not.  It tells investors how well a company is turning their capital into profits.  The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital.  The employed capital is calculated by subrating current liabilities from total assets.  Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years.  The ROIC Quality of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 6.281736.  This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC.  The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets).  The ROIC 5 year average of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 0.382892.

Shareholder Yield

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction.  The Shareholder Yield of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 0.016052.  This percentage is calculated by adding the dividend yield plus the percentage of shares repurchased.  Dividends are a common way that companies distribute cash to their shareholders.  Similarly, cash repurchases and a reduction of debt can increase the shareholder value, too.  Another way to determine the effectiveness of a company’s distributions is by looking at the Shareholder yield (Mebane Faber).  The Shareholder Yield (Mebane Faber) of Healthcare Services Group, Inc. NasdaqGS:HCSG is 0.02048.  This number is calculated by looking at the sum of the dividend yield plus percentage of sales repurchased and net debt repaid yield.

The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 56.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 50.

Investors may be interested in viewing the Gross Margin score on shares of Healthcare Services Group, Inc. (NasdaqGS:HCSG). The name currently has a score of 11.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

ERP5 Rank

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Healthcare Services Group, Inc. (NasdaqGS:HCSG) is 6630. The lower the ERP5 rank, the more undervalued a company is thought to be.

C-Score – Montier

Healthcare Services Group, Inc. (NasdaqGS:HCSG) currently has a Montier C-score of 1.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

F Score

At the time of writing, Healthcare Services Group, Inc. (NasdaqGS:HCSG) has a Piotroski F-Score of 4. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Investors may be looking ahead to the next couple of quarters trying to gauge whether the bulls will stay in charge or if the bears will start to take over. Of course, nobody knows for sure which way the market will turn, but being ready for any situation can greatly help the investor prepare. Many investors will be trying to find that balance between being too aggressive and too conservative with stock selection. This can be a tricky aspect to address as there are so many different factors that can come into play. Studying the important pieces of economic data on a regular basis can help with crafting a legitimate hypothesis about where stocks will be in the future.

The MF Rank developed by hedge fund manager Joel Greenblatt, is intended spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks. Nabors Industries Ltd. (NYSE:NBR) has a current MF Rank of 12251.

Some investors will scour the markets looking for cheap, quality stocks. These stocks can be attractive for investors looking to find a bargain that could turn into a big winner. Investors may be cautious when searching for these types of stocks. Often times, a stock will see a huge jump and then everyone will hop on the bandwagon to buy without checking into the fundamentals. Sometimes this strategy may work out, but in many cases, the stock has already made the run and become too expensive to add to the portfolio. Conducting diligent research and constantly adding to the individual’s overall market education level may help the investor sift through the sea of stocks and find those names that are really worth getting into.

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow.  The FCF Growth of Nabors Industries Ltd. (NYSE:NBR) is -1.773081.  Free cash flow (FCF) is the cash produced by the company minus capital expenditure.  This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.  The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow.  The FCF Score of Nabors Industries Ltd. (NYSE:NBR) is -0.306941.  Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

Investors may be interested in viewing the Gross Margin score on shares of Nabors Industries Ltd. (NYSE:NBR). The name currently has a score of 33.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

The Return on Invested Capital (aka ROIC) for Nabors Industries Ltd. (NYSE:NBR) is -0.015823.  The Return on Invested Capital is a ratio that determines whether a company is profitable or not.  It tells investors how well a company is turning their capital into profits.  The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital.  The employed capital is calculated by subrating current liabilities from total assets.  Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years.  The ROIC Quality of Nabors Industries Ltd. (NYSE:NBR) is 2.498526.  This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC.  The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets).  The ROIC 5 year average of Nabors Industries Ltd. (NYSE:NBR) is 0.017797.

Shareholder Yield

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction.  The Shareholder Yield of Nabors Industries Ltd. (NYSE:NBR) is -0.115449.  This percentage is calculated by adding the dividend yield plus the percentage of shares repurchased.  Dividends are a common way that companies distribute cash to their shareholders.  Similarly, cash repurchases and a reduction of debt can increase the shareholder value, too.  Another way to determine the effectiveness of a company’s distributions is by looking at the Shareholder yield (Mebane Faber).  The Shareholder Yield (Mebane Faber) of Nabors Industries Ltd. NYSE:NBR is 0.19679.  This number is calculated by looking at the sum of the dividend yield plus percentage of sales repurchased and net debt repaid yield.

The Value Composite One (VC1) is a method that investors use to determine a company’s value.  The VC1 of Nabors Industries Ltd. (NYSE:NBR) is 20.  A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company.  The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings.  Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield.  The Value Composite Two of Nabors Industries Ltd. (NYSE:NBR) is 34.

Key Ratios

Nabors Industries Ltd. (NYSE:NBR) presently has a current ratio of 1.92. The current ratio, also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations.

Nabors Industries Ltd. (NYSE:NBR)’s Leverage Ratio was recently noted as 0.441248. This ratio is calculated by dividing total debt by total assets plus total assets previous year, divided by two. The leverage of a company is relative to the amount of debt on the balance sheet. This ratio is often viewed as one measure of the financial health of a firm.

The Price to book ratio is the current share price of a company divided by the book value per share.  The Price to Book ratio for Nabors Industries Ltd. NYSE:NBR is 0.504808.  A lower price to book ratio indicates that the stock might be undervalued.  Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value.  The Price to Cash Flow for Nabors Industries Ltd. (NYSE:NBR) is 4.185151.  This ratio is calculated by dividing the market value of a company by cash from operating activities.  Additionally, the price to earnings ratio is another popular way for analysts and investors to determine a company’s profitability.  The price to earnings ratio for Nabors Industries Ltd. (NYSE:NBR) is -2.046639. This ratio is found by taking the current share price and dividing by earnings per share.

When it comes to investing in the equity market, discipline can play a major role in achieving ones goals. A few bad moves can send the investor’s confidence spiraling. Acting purely on emotion can lead to impulsive decisions that may cause the losses to pile up. Creating a solid plan and following through with the plan can help investors stay on track and focus on the proper details. Markets are constantly going up and down and the investing ride can sometimes be a bumpy one. Being able to see the big picture and focus on the important data can help keep the investor tuned in to the right channel. Investors who expect to jump into the market and immediately start raking in the profits may find out fairly quickly that trading without a plan can be a recipe for defeat.

Stocks to Watch: Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL), Tenet Healthcare Corporation (NYSE:THC): Are Shares Undervalued?

by

Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) has a current MF Rank of 15749. Developed by hedge fund manager Joel Greenblatt, the intention of the formula is to spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks.

When undertaking stock analysis, investors might be searching for companies that are presently undervalued. Undervalued stocks may provide a higher chance of realizing big gains. Finding undervalued stocks that are high quality can be the biggest challenge for the investor. Many investors will dig into the numbers and look for companies that have been consistently making lots of money and performing well on the earnings front.

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow. The FCF Growth of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is -0.089581. Free cash flow (FCF) is the cash produced by the company minus capital expenditure. This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends.

The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow. The FCF Score of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is 0.670197. Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

The Return on Invested Capital (aka ROIC) for Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is -4.691731. The Return on Invested Capital is a ratio that determines whether a company is profitable or not. It tells investors how well a company is turning their capital into profits. The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital. The employed capital is calculated by subrating current liabilities from total assets. Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years. The ROIC Quality of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is . This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets). The ROIC 5 year average of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is .

Shareholder Yield

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction. The Shareholder Yield of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is -0.099343. This percentage is calculated by adding the dividend yield plus the percentage of shares repurchased. Dividends are a common way that companies distribute cash to their shareholders. Similarly, cash repurchases and a reduction of debt can increase the shareholder value, too. Another way to determine the effectiveness of a company’s distributions is by looking at the Shareholder yield (Mebane Faber). The Shareholder Yield (Mebane Faber) of Madrigal Pharmaceuticals, Inc. NasdaqCM:MDGL is -0.08360. This number is calculated by looking at the sum of the dividend yield plus percentage of sales repurchased and net debt repaid yield.

The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is 69. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is 74.

Investors may be interested in viewing the Gross Margin score on shares of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL). The name currently has a score of 50.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

ERP5 Rank

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC. The ERP5 of Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) is 18996. The lower the ERP5 rank, the more undervalued a company is thought to be.

C-Score – Montier

Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) currently has a Montier C-score of -1.00000. This indicator was developed by James Montier in an attempt to identify firms that were cooking the books in order to appear better on paper. The score ranges from zero to six where a 0 would indicate no evidence of book cooking, and a 6 would indicate a high likelihood. A C-score of -1 would indicate that there is not enough information available to calculate the score. Montier used six inputs in the calculation. These inputs included a growing difference between net income and cash flow from operations, increasing receivable days, growing day’s sales of inventory, increasing other current assets, decrease in depreciation relative to gross property plant and equipment, and high total asset growth.

F Score

At the time of writing, Madrigal Pharmaceuticals, Inc. (NasdaqCM:MDGL) has a Piotroski F-Score of 3. The F-Score may help discover companies with strengthening balance sheets. The score may also be used to spot the weak performers. Joseph Piotroski developed the F-Score which employs nine different variables based on the company financial statement. A single point is assigned to each test that a stock passes. Typically, a stock scoring an 8 or 9 would be seen as strong. On the other end, a stock with a score from 0-2 would be viewed as weak.

Investors may be looking ahead to the next couple of quarters trying to gauge whether the bulls will stay in charge or if the bears will start to take over. Of course, nobody knows for sure which way the market will turn, but being ready for any situation can greatly help the investor prepare. Many investors will be trying to find that balance between being too aggressive and too conservative with stock selection. This can be a tricky aspect to address as there are so many different factors that can come into play. Studying the important pieces of economic data on a regular basis can help with crafting a legitimate hypothesis about where stocks will be in the future.

The MF Rank developed by hedge fund manager Joel Greenblatt, is intended spot high quality companies that are trading at an attractive price. The formula uses ROIC and earnings yield ratios to find quality, undervalued stocks. In general, companies with the lowest combined rank may be the higher quality picks. Tenet Healthcare Corporation (NYSE:THC) has a current MF Rank of 2380.

Some investors will scour the markets looking for cheap, quality stocks. These stocks can be attractive for investors looking to find a bargain that could turn into a big winner. Investors may be cautious when searching for these types of stocks. Often times, a stock will see a huge jump and then everyone will hop on the bandwagon to buy without checking into the fundamentals. Sometimes this strategy may work out, but in many cases, the stock has already made the run and become too expensive to add to the portfolio. Conducting diligent research and constantly adding to the individual’s overall market education level may help the investor sift through the sea of stocks and find those names that are really worth getting into.

Free Cash Flow Growth (FCF Growth) is the free cash flow of the current year minus the free cash flow from the previous year, divided by last year’s free cash flow. The FCF Growth of Tenet Healthcare Corporation (NYSE:THC) is 2.324723. Free cash flow (FCF) is the cash produced by the company minus capital expenditure. This cash is what a company uses to meet its financial obligations, such as making payments on debt or to pay out dividends. The Free Cash Flow Score (FCF Score) is a helpful tool in calculating the free cash flow growth with free cash flow stability – this gives investors the overall quality of the free cash flow. The FCF Score of Tenet Healthcare Corporation (NYSE:THC) is 1.364749. Experts say the higher the value, the better, as it means that the free cash flow is high, or the variability of free cash flow is low or both.

Investors may be interested in viewing the Gross Margin score on shares of Tenet Healthcare Corporation (NYSE:THC). The name currently has a score of 20.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

The Return on Invested Capital (aka ROIC) for Tenet Healthcare Corporation (NYSE:THC) is 0.208491. The Return on Invested Capital is a ratio that determines whether a company is profitable or not. It tells investors how well a company is turning their capital into profits. The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital. The employed capital is calculated by subrating current liabilities from total assets. Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years. The ROIC Quality of Tenet Healthcare Corporation (NYSE:THC) is 7.437708. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets). The ROIC 5 year average of Tenet Healthcare Corporation (NYSE:THC) is 0.120881.

Shareholder Yield

The Shareholder Yield is a way that investors can see how much money shareholders are receiving from a company through a combination of dividends, share repurchases and debt reduction. The Shareholder Yield of Tenet Healthcare Corporation (NYSE:THC) is -0.015465. This percentage is calculated by adding the dividend yield plus the percentage of shares repurchased. Dividends are a common way that companies distribute cash to their shareholders. Similarly, cash repurchases and a reduction of debt can increase the shareholder value, too. Another way to determine the effectiveness of a company’s distributions is by looking at the Shareholder yield (Mebane Faber). The Shareholder Yield (Mebane Faber) of Tenet Healthcare Corporation NYSE:THC is 0.03681. This number is calculated by looking at the sum of the dividend yield plus percentage of sales repurchased and net debt repaid yield.

The Value Composite One (VC1) is a method that investors use to determine a company’s value. The VC1 of Tenet Healthcare Corporation (NYSE:THC) is 22. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. The VC1 is calculated using the price to book value, price to sales, EBITDA to EV, price to cash flow, and price to earnings. Similarly, the Value Composite Two (VC2) is calculated with the same ratios, but adds the Shareholder Yield. The Value Composite Two of Tenet Healthcare Corporation (NYSE:THC) is 32.

Key Ratios

Tenet Healthcare Corporation (NYSE:THC) presently has a current ratio of 1.20. The current ratio, also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations.

Tenet Healthcare Corporation (NYSE:THC)’s Leverage Ratio was recently noted as 0.647508. This ratio is calculated by dividing total debt by total assets plus total assets previous year, divided by two. The leverage of a company is relative to the amount of debt on the balance sheet. This ratio is often viewed as one measure of the financial health of a firm.

The Price to book ratio is the current share price of a company divided by the book value per share. The Price to Book ratio for Tenet Healthcare Corporation NYSE:THC is -20.249114. A lower price to book ratio indicates that the stock might be undervalued. Similarly, Price to cash flow ratio is another helpful ratio in determining a company’s value. The Price to Cash Flow for Tenet Healthcare Corporation (NYSE:THC) is 2.297087. This ratio is calculated by dividing the market value of a company by cash from operating activities. Additionally, the price to earnings ratio is another popular way for analysts and investors to determine a company’s profitability. The price to earnings ratio for Tenet Healthcare Corporation (NYSE:THC) is 21.708510. This ratio is found by taking the current share price and dividing by earnings per share.

When it comes to investing in the equity market, discipline can play a major role in achieving ones goals. A few bad moves can send the investor’s confidence spiraling. Acting purely on emotion can lead to impulsive decisions that may cause the losses to pile up. Creating a solid plan and following through with the plan can help investors stay on track and focus on the proper details. Markets are constantly going up and down and the investing ride can sometimes be a bumpy one. Being able to see the big picture and focus on the important data can help keep the investor tuned in to the right channel. Investors who expect to jump into the market and immediately start raking in the profits may find out fairly quickly that trading without a plan can be a recipe for defeat.